Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Action Urged On Usability Testing In Elderly, Minority Patients For Self-Management Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA needs to better enforce the inclusion of elderly and minority patients in usability testing for glucose meters and other personal monitoring devices, says a University of Maryland human-factors engineer. Patients in these subgroups are most likely to suffer physical ailments or have gaps in health or technological literacy that challenge their ability to make good use of the products, she said.

You may also be interested in...

Products Lacking Good Subgroup Data Shouldn’t Be Approved, Patient, Medical Groups Tell FDA

FDA should more strongly enforce requirements for adequate demographic subgroup representation in clinical trials for devices and other medical products, participants said at an April 1 meeting on collection and analysis of clinical trial subpopulation data to support product registration.

FDA To Clarify Scope Of Devices Covered By Human Factors Guidance

FDA is reviewing 600-plus comments on its draft human factors guidance and plans to "be much more specific" in the final version about the types of devices subject to the new data recommendations.

APACMed 2020: Healthineers Evolves Therapy Remit And Makes All Asia An Equal Priority

Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts